Multiplex ligation-dependent probe amplification
Multiplex ligation-dependent probe amplification is a variation of the multiplex polymerase chain reaction that permits amplification of multiple targets with only a single primer pair. It detects copy number changes at the molecular level, and software programs are used for analysis. Identification of deletions or duplications can indicate pathogenic mutations, thus MLPA is an important diagnostic tool used in clinical pathology laboratories worldwide.
History
Multiplex ligation-dependent probe amplification was invented by Jan Schouten, a Dutch scientist. The method was first described in 2002 in the scientific journal Nucleic Acid Research. The first applications included the detection of exon deletions in the human genes BRCA1, MSH2 and MLH1, which are linked to hereditary breast and colon cancer. Now MLPA is used to detect hundreds of hereditary disorders, as well as for tumour profiling.Description
MLPA quantifies the presence of particular sequences in a sample of DNA, using a specially designed probe pair for each target sequence of interest. The process consists of multiple steps:- The sample DNA is denatured, resulting in single-stranded sample DNA.
- Pairs of probes are hybridized to the sample DNA, with each probe pair designed to query for the presence of a particular DNA sequence.
- Ligase is applied to the hybridized DNA, combining probe pairs that are hybridized immediately next to each other into a single strand of DNA that can be amplified by PCR.
- PCR amplifies all probe pairs that have been successfully ligated, using fluorescently labeled PCR primers.
- The PCR products are quantified, typically by electrophoresis.
Various techniques including DGGE, DHPLC, and SSCA effectively identify SNPs and small insertions and deletions. MLPA, however, is one of the only accurate, time-efficient techniques to detect genomic deletions and insertions, which are frequent causes of cancers such as hereditary non-polyposis colorectal cancer, breast, and ovarian cancer. MLPA can successfully and easily determine the relative copy number of all exons within a gene simultaneously with high sensitivity.
Relative ploidy
An important use of MLPA is to determine relative ploidy. For example, probes may be designed to target various regions of chromosome 21 of a human cell. The signal strengths of the probes are compared with those obtained from a reference DNA sample known to have two copies of the chromosome. If an extra copy is present in the test sample, the signals are expected to be 1.5 times the intensities of the respective probes from the reference. If only one copy is present the proportion is expected to be 0.5. If the sample has two copies, the relative probe strengths are expected to be equal.Dosage quotient analysis
Dosage quotient analysis is the usual method of interpreting MLPA data. If a and b are the signals from two amplicons in the patient sample, and A and B are the corresponding amplicons in the experimental control, then the dosage quotient DQ = /. Although dosage quotients may be calculated for any pair of amplicons, it is usually the case that one of the pair is an internal reference probe.Applications
MLPA facilitates the amplification and detection of multiple targets with a single primer pair. In a standard multiplex PCR reaction, each fragment needs a unique amplifying primer pair. These primers being present in a large quantity result in various problems such as dimerization and false priming. With MLPA, amplification of probes can be achieved. Thus, many sequences can be amplified and quantified using just a single primer pair. MLPA reaction is fast, inexpensive and very simple to perform.MLPA has a variety of applications including detection of mutations and single nucleotide polymorphisms, analysis of DNA methylation, relative mRNA quantification, chromosomal characterisation of cell lines and tissue samples, detection of gene copy number, detection of duplications and deletions in human cancer predisposition genes such as BRCA1, BRCA2, hMLH1 and hMSH2 and aneuploidy determination. MLPA has potential application in prenatal diagnosis both invasive and noninvasive.
Recent studies have shown that MLPA is a robust technique for inversion characterisation.
Variants
iMLPA
Giner-Delgado, Carla, et al. described a variant of MLPA combining it with iPCR. They call these new method iMLPA and its procedure is the same as MLPA but there are necessary two additional steps at the beginning:- First, a DNA treatment with restriction enzymes that cut on both sides of the region of interest is necessary.
- The fragments obtained from digestion are recircularized and linked
The next step continues with the typical MLPA protocol.